Copyright
©The Author(s) 1998.
World J Gastroenterol. Feb 15, 1998; 4(1): 33-37
Published online Feb 15, 1998. doi: 10.3748/wjg.v4.i1.33
Published online Feb 15, 1998. doi: 10.3748/wjg.v4.i1.33
Table 2 Mean doses of embolic agents and anticancer drugs
| TSCTV courses | No of patients | Embolic agents | Anticancer drugs | |||
| SBMs (mg) | LUF (mL) | SB (mg) | ACR (mg) | CDDP (mg) | ||
| 1 | 80 | 145.0 | 22.3 | 8.7 | 41.8 | 80.0 |
| 2 | 72 | 114.3 | 13.7 | 6.9 | 37.9 | 75.6 |
| 3 | 56 | 107.8 | 15.4 | 6.5 | 40.8 | 76.4 |
| 4 | 24 | 91.7 | 11.7 | 5.5 | 40.0 | 80.0 |
| 5-6 | 6 | 100.0 | 11.2 | 6.0 | 40.0 | 80.0 |
| Mean | 240 | 111.8 | 14.9 | 6.7 | 40.1 | 78.4 |
- Citation: Fan J, Ten GJ, He SC, Guo JH, Yang DP, Weng GY. Arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 1998; 4(1): 33-37
- URL: https://www.wjgnet.com/1007-9327/full/v4/i1/33.htm
- DOI: https://dx.doi.org/10.3748/wjg.v4.i1.33